Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 3/2018

01-03-2018 | Original Article – Cancer Research

The use of complementary and alternative medicine by patients in routine care and the risk of interactions

Authors: Rachel Firkins, Hannah Eisfeld, Christina Keinki, Jens Buentzel, Andreas Hochhaus, Thorsten Schmidt, Jutta Huebner

Published in: Journal of Cancer Research and Clinical Oncology | Issue 3/2018

Login to get access

Abstract

Background

Patients suffering from cancer often make use of complementary and alternative medicine (CAM). Only few data exist on the prevalence and clinical significance of interactions of a biological CAM method and conventional drugs.

Methods

From February 2014 to March 2016, consecutive patients from five oncological practices in Germany were asked to fulfill a standardized questionnaire regarding use of CAM. Data on diagnosis, date of first diagnosis, ECOG and the past and current treatment were derived from the patients’ files. Interactions were evaluated by systematically using a database on potential interactions.

Results

From 1000 patients asked to participate, we received a total of 720 questionnaires of which 711 were completed and eligible for evaluation. 29% of the patients reported any CAM usage. Women showed a significantly higher use of CAM with 35.6 versus 23.6% of men. For 54.9% of CAM users (15.9% of all patients), we found a combination of conventional drugs and biological based CAM methods with a risk for interactions. Vitamins A, C and E were the most frequently used CAM substances in these cases (39.3%), followed by herbs with 17.5%.

Conclusion

There was a risk of interactions between a biological CAM method and conventional drugs in 54.9% of the patients using CAM. To raise knowledge on interactions a better training for doctors with respect to CAM is strongly needed. Furthermore, patients’ awareness should also be raised and communication between physician and patient on the topic improved.
Literature
go back to reference Berretta M, Della Pepa C, Tralongo P, Fulvi A, Martellotta F, Lleshi A et al (2016) Use of complementary and alternative medicine (CAM) in cancer patients: an Italian multicenter survey. Oncotarget 8(15):24401–24414PubMedCentral Berretta M, Della Pepa C, Tralongo P, Fulvi A, Martellotta F, Lleshi A et al (2016) Use of complementary and alternative medicine (CAM) in cancer patients: an Italian multicenter survey. Oncotarget 8(15):24401–24414PubMedCentral
go back to reference Cassileth BR, Lucarelli CD (2003) Herb–drug interactions in oncology. BC Decker, Inc, Hamilton Cassileth BR, Lucarelli CD (2003) Herb–drug interactions in oncology. BC Decker, Inc, Hamilton
go back to reference Hillen MA, de Haes HCJM., Stalpers LJA, Klinkenbijl JHG, Eddes EH, Butow PN et al (2014) How can communication by oncologists enhance patients’ trust? An experimental study. Ann Oncol 25(4):896–901CrossRefPubMed Hillen MA, de Haes HCJM., Stalpers LJA, Klinkenbijl JHG, Eddes EH, Butow PN et al (2014) How can communication by oncologists enhance patients’ trust? An experimental study. Ann Oncol 25(4):896–901CrossRefPubMed
go back to reference Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M (2012) How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 11(3):187–203CrossRefPubMed Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M (2012) How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 11(3):187–203CrossRefPubMed
go back to reference Huebner J, Muenstedt K, Muecke R, Micke O, Stoll C, Kleeberg UR et al (2013) Counseling cancer patients on complementary and alternative medicine: background, theory, and implementation of nationwide counseling facilities. Strahlenther Onkol 189(8):613–617CrossRef Huebner J, Muenstedt K, Muecke R, Micke O, Stoll C, Kleeberg UR et al (2013) Counseling cancer patients on complementary and alternative medicine: background, theory, and implementation of nationwide counseling facilities. Strahlenther Onkol 189(8):613–617CrossRef
go back to reference Huebner J, Muenstedt K, Prott FJ, Stoll C, Micke O, Buentzel J et al (2014a) Online survey of patients with breast cancer on complementary and alternative medicine. Breast Care (Basel Switzerland) 9(1):60–63CrossRef Huebner J, Muenstedt K, Prott FJ, Stoll C, Micke O, Buentzel J et al (2014a) Online survey of patients with breast cancer on complementary and alternative medicine. Breast Care (Basel Switzerland) 9(1):60–63CrossRef
go back to reference Huebner J, Micke O, Muecke R, Buentzel J, Prott FJ, Kleeberg U et al (2014b) User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center. Anticancer Res 34(2):943–948PubMed Huebner J, Micke O, Muecke R, Buentzel J, Prott FJ, Kleeberg U et al (2014b) User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center. Anticancer Res 34(2):943–948PubMed
go back to reference Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler KC, Kurschat P et al (2016) Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma. Med Oncol 33(5):52CrossRefPubMed Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler KC, Kurschat P et al (2016) Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma. Med Oncol 33(5):52CrossRefPubMed
go back to reference Loquai C, Schmidtmann I, Garzarolli M, Kaatz M, Kahler KC, Kurschat P et al (2017) Interactions from complementary and alternative medicine in patients with melanoma. Melanoma Res 27(3):238–242CrossRefPubMed Loquai C, Schmidtmann I, Garzarolli M, Kaatz M, Kahler KC, Kurschat P et al (2017) Interactions from complementary and alternative medicine in patients with melanoma. Melanoma Res 27(3):238–242CrossRefPubMed
go back to reference Meijerman I, Beijnen JH, Schellens JHM (2006) Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist 11(7):742–752CrossRefPubMed Meijerman I, Beijnen JH, Schellens JHM (2006) Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist 11(7):742–752CrossRefPubMed
go back to reference Pourroy B, Letellier C, Helvig A, Chanet B, De Crozals F, Alessandra C (2017). Development of a rapid risk evaluation tool for herbs/drugs interactions in cancer patients: a multicentric experience in south of France. Eur J Cancer Care 26(6):e12752CrossRef Pourroy B, Letellier C, Helvig A, Chanet B, De Crozals F, Alessandra C (2017). Development of a rapid risk evaluation tool for herbs/drugs interactions in cancer patients: a multicentric experience in south of France. Eur J Cancer Care 26(6):e12752CrossRef
go back to reference Saxe GA, Madlensky L, Kealey S, Wu DPH, Freeman KL, Pierce JP (2008) Disclosure to physicians of CAM use by breast cancer patients: findings from the Women’s Healthy Eating and Living Study. Integr Cancer Ther 7(3):122–129CrossRefPubMedPubMedCentral Saxe GA, Madlensky L, Kealey S, Wu DPH, Freeman KL, Pierce JP (2008) Disclosure to physicians of CAM use by breast cancer patients: findings from the Women’s Healthy Eating and Living Study. Integr Cancer Ther 7(3):122–129CrossRefPubMedPubMedCentral
go back to reference Wortmann JK, Bremer A, Eich H, Wortmann HK, Schuster A, Fühner J et al (2016) Use of complementary and alternative medicine by patients with cancer: a cross-sectional study at different points of cancer care. Med Oncol 33(7):78CrossRefPubMed Wortmann JK, Bremer A, Eich H, Wortmann HK, Schuster A, Fühner J et al (2016) Use of complementary and alternative medicine by patients with cancer: a cross-sectional study at different points of cancer care. Med Oncol 33(7):78CrossRefPubMed
go back to reference Zeller T, Muenstedt K, Stoll C, Schweder J, Senf B, Ruckhaeberle E et al (2013) Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin Oncol 139(3):357–365CrossRefPubMed Zeller T, Muenstedt K, Stoll C, Schweder J, Senf B, Ruckhaeberle E et al (2013) Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin Oncol 139(3):357–365CrossRefPubMed
Metadata
Title
The use of complementary and alternative medicine by patients in routine care and the risk of interactions
Authors
Rachel Firkins
Hannah Eisfeld
Christina Keinki
Jens Buentzel
Andreas Hochhaus
Thorsten Schmidt
Jutta Huebner
Publication date
01-03-2018
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 3/2018
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-018-2587-7

Other articles of this Issue 3/2018

Journal of Cancer Research and Clinical Oncology 3/2018 Go to the issue